LiveActive security incident?Get immediate response
CVE Record

CVE-2022-42045: Certain Zemana products are vulnerable to Arbitrary code injection.

Certain Zemana products are vulnerable to Arbitrary code injection. This affects Watchdog Anti-Malware 4.1.422 and Zemana AntiMalware 3.2.28.

UnknownCVSS not scoredNot KEV-listedUpdated
Glexia's TakeAutomated analysisunknown

Security readout for executives and security teams

Plain-English summary

CVE-2022-42045 describes arbitrary code injection in specific Zemana endpoint security products. The named affected versions are Watchdog Anti-Malware 4.1.422 and Zemana AntiMalware 3.2.28. The public bundle does not provide CVSS, a vendor fix, or evidence of active exploitation.

Executive priority

Prioritize discovery before emergency action. The issue is potentially serious because it concerns code injection in security software, but the public data lacks severity scoring, exploit evidence, and confirmed remediation details.

Technical view

The CVE maps to CWE-94, indicating improper control of code generation or injection. Available source data names two affected product versions but gives no technical root cause, privilege context, attack vector, or patch version. Treat exposure assessment as product/version inventory first.

Likely exposure

Exposure is limited, based on available evidence, to systems running Watchdog Anti-Malware 4.1.422 or Zemana AntiMalware 3.2.28. The CVE affected-product metadata is incomplete and lists vendor/product as n/a outside the description.

Exploitation context

The source bundle shows KEV status as false and provides no cited evidence of active exploitation. A public GitHub reference exists, but the bundle does not include enough detail to confirm exploit maturity, prerequisites, or real-world use.

Researcher notes

The record is sparse: CWE-94, two affected versions, and one GitHub reference. Key missing facts include attack vector, required privileges, user interaction, persistence impact, and fixed build. Avoid extrapolating beyond the named products and versions.

Mitigation direction

  • Inventory endpoints for the two named Zemana product versions.
  • Check Zemana or product-maintainer guidance for fixed versions or removal advice.
  • Upgrade, remove, or replace affected versions when vendor guidance supports it.
  • Apply endpoint least-privilege controls on systems running affected software.
  • Monitor affected hosts for unusual child processes or code-loading behavior.

Validation and detection

  • Query asset inventory for exact Watchdog Anti-Malware and Zemana AntiMalware versions.
  • Confirm whether version 4.1.422 or 3.2.28 is installed.
  • Review vendor release notes or advisories for remediation details.
  • Check whether affected hosts are internet-exposed or broadly user-accessible.
  • Review endpoint telemetry for suspicious execution linked to these products.
Prepared
Confidence
medium
Sources
3

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · medium confidence lookup

CWE-94: Code execution behavior lookup

Code execution and unsafe deserialization weaknesses often justify reviewing execution behavior and process telemetry. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
description · low confidence lookup

Execution behavior lookup

The CVE wording references code or command execution, so execution technique review may help defensive triage. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2022-42045 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
n/an/an/aListed
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-94 · source CWE mapping

Improper Control of Generation of Code ('Code Injection')

Improper Control of Generation of Code ('Code Injection') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.